Dr. David Martín-Hernández

My scientific career began collaborating at the Cancer Research Institute. After my BSc in Biotechnology at the USAL, I studied the MSc in Psychopharmacology and Drugs of Abuse at the UCM with distinction on my TFM. My passion for science led me to become a Ph.D. student at the G12 of the CIBERSAM located in the Medicine School UCM. In 2017, I achieved cum laude distinction on my Doctoral Thesis entitled Origin and consequences of inflammation in depression. My first postdoctoral experience was in the Faculty of Medicine UCM between 2018 and 2019. In 2020, I was granted a Juan de la Cierva Formación postdoctoral fellowship and joined the Psychiatry group at the IiSGM. In 2021, I voluntarily rejected a Sara Borrell postdoctoral fellowship for a 5-year Ley de la Ciencia CIBERSAM postdoctoral contract. The acquired multidisciplinary scientific expertise from a translational perspective revolves around the immune basis and new pharmacological targets in psychiatric disorders. I have delved into the possible role of the gut and oral microbiomes in depression, describing neuroimmune-related alterations and if current treatments can modulate them. In the last years, I have led research lines focused on the microbiome composition and the sphingosine-1-phosphate pathways, which act on the interplay of the innate and adaptive immune systems and control barrier permeability.